Evaluate whether additional laser vision correction may be appropriate after your initial procedure. This guide covers corneal thickness, stability requirements, and key screening criteria.
Last reviewed: 2026-05-06
8 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Corneal thickness determines enhancement eligibility—remaining stromal bed must be at least 250-270 microns for safety.
Refractive stability over time is essential—prescriptions should remain consistent before any retreatment consideration.
Ocular surface conditions like dry eye must be managed before surgical evaluation.
Not all patients are candidates; alternatives exist when enhancement is not recommended.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Enhancement Procedures
An enhancement procedure refers to additional laser vision correction performed after an initial refractive surgery when residual refractive error persists, regression occurs, or visual needs change over time. The evaluation process for enhancement is often more complex than the initial screening because your surgeon must account for tissue removed during the first procedure and how your cornea healed.
The American Refractive Surgery Council emphasizes that comprehensive screening for enhancement candidacy should include all relevant elements of a standard preoperative evaluation, with additional attention to corneal architecture and healing response from the original procedure (S1). This means the screening process may take longer and require more sophisticated diagnostic imaging than your initial consultation.
For patients considering enhancement, reviewing eye surgery resources can help establish context for how enhancement fits within broader vision correction options.
Common reasons patients consider enhancement
Residual refractive error that was not fully corrected initially
Regression—gradual return of original prescription
Changes in vision due to age-related developments
Desire for improved visual acuity as needs evolve
Core Candidacy Requirements
Enhancement candidacy depends on several interconnected factors that your surgeon will evaluate during a comprehensive assessment. These criteria help determine whether additional treatment can be performed safely and effectively.
Corneal Thickness Evaluation
Corneal thickness remains the most critical anatomical factor in determining enhancement candidacy. Normal corneal thickness is approximately 520 microns, and after the initial LASIK procedure, a residual stromal bed of at least 250 to 270 microns should be preserved to maintain corneal stability and prevent ectasia (S2). When evaluating patients for enhancement, surgeons calculate whether sufficient corneal tissue remains to safely perform additional ablation while maintaining this minimum threshold.
The femtosecond laser creates a LASIK flap of approximately 110 microns during the initial procedure, and the excimer laser removes approximately 14 to 16 microns of corneal tissue per diopter of correction (S2). These calculations become especially important during enhancement evaluations because the corneal tissue removed during the original surgery reduces the remaining thickness available for additional treatment.
Refractive Stability and Measurements
A fundamental requirement for any enhancement procedure is demonstrating stable refractive measurements over time. The American Refractive Surgery Council notes that vision prescriptions should remain consistent for a minimum period before enhancement surgery is considered (S1). This stability requirement helps distinguish true residual error from transient fluctuations that may resolve naturally without intervention.
Patients experiencing changes in their vision should undergo serial refractive assessments to establish whether the shift represents a permanent refractive change requiring treatment or a temporary variation related to factors such as dry eye, medication changes, or hormonal influences.
Ocular Surface Assessment
The condition of the ocular surface significantly impacts both the accuracy of refractive measurements and the safety of additional surgical intervention. Dry eye disease, which commonly occurs after initial LASIK surgery, should be identified and optimally managed before any enhancement consideration (S3). Uncontrolled ocular surface disease can compromise surgical outcomes and lead to inaccurate preoperative measurements.
Corneal topography mapping becomes essential in enhancement evaluations to detect irregular astigmatism, epithelial mapping abnormalities, or early signs of corneal ectasia that would contraindicate additional laser treatment (S1).
Contraindications and When Enhancement Is Not Recommended
Certain conditions may preclude enhancement surgery regardless of other factors. Understanding these contraindications helps you have informed discussions with your provider about your options.
Absolute contraindications
Insufficient corneal thickness: When residual stromal bed measurements fall below the 250-micron threshold, additional laser ablation poses unacceptable risks for corneal instability (S2).
Active ocular disease: Uncontrolled glaucoma, active corneal infections, severe dry eye syndrome, or inflammatory conditions affecting the eye represent contraindications (S3).
Keratoconus or corneal ectasia: Patients demonstrating signs of progressive corneal thinning or irregularity are not candidates for additional laser correction.
Pregnancy or nursing: Hormonal changes can affect refractive measurements, making it inappropriate to proceed until vision stabilizes (S1).
Relative Considerations
Several factors require careful risk-benefit analysis but do not automatically disqualify patients from enhancement:
Age-related changes: Patients over 40 may develop presbyopia, which laser correction cannot address. Enhancement for distance vision may leave patients dependent on reading glasses for near tasks (S3).
High initial prescriptions: Patients with very high myopia (-8.00 D or greater) originally may have had significant tissue removal, potentially limiting enhancement options.
Multiple previous procedures: Patients who have already undergone more than one enhancement carry increased risk and may have limited remaining corneal tissue.
Alternative Options When Enhancement Is Not Suitable
When enhancement is not recommended based on the evaluation criteria, several alternatives may address your visual needs. Surface ablation (PRK) may be appropriate for some patients who are not candidates for flap-lift enhancement, as it does not require creating a new flap but instead works on the corneal surface (S2).
Patients exploring alternative refractive surgery options should discuss with their surgeon which approach aligns best with their corneal anatomy and visual goals.
Specialty contact lenses, including rigid gas permeable lenses, may provide excellent visual correction for patients who cannot safely undergo additional surgery. For patients with significant corneal irregularities, lens-based procedures such as refractive lens exchange may be considered after thorough evaluation.
Feature
Option
Best For
Considerations
Enhancement (LASIK/PRK)
Adequate corneal thickness, stable prescription
Additional correction after initial procedure
Surface Ablation (PRK)
Flap complications risk, certain enhancement cases
No flap creation, longer recovery
Specialty Contact Lenses
Insufficient tissue for surgery, corneal irregularities
Non-surgical, requires fitting expertise
Refractive Lens Exchange
Presbyopia, high prescriptions
Intraocular procedure, different risk profile
Questions to Ask Your Provider
During your candidacy evaluation, seek clear answers to these key questions:
What is my remaining corneal thickness, and does it meet the minimum threshold for safe enhancement?
What diagnostic tests will be performed to evaluate my ocular surface and corneal architecture?
What are the specific risks in my case, given my corneal thickness and healing history?
Would surface ablation or flap lift be recommended for my situation, and why?
What is the realistic expected outcome for my prescription range and visual needs?
What alternative options exist if I am not a candidate for enhancement?
How will presbyopia or future age-related changes affect my results?
Patient Action Checklist
Key takeaways
Request a comprehensive enhancement evaluation—not all surgeons perform the same screening protocol.
Ensure corneal thickness measurements are verified with clinical pachymetry, not estimated.
Confirm refractive stability with multiple measurements taken over time before proceeding.
Address dry eye or ocular surface conditions before any surgical consideration.
Understand that pregnancy, nursing, and unstable prescriptions are timing considerations, not permanent exclusions.
Verify your surgeon has experience with enhancement procedures specifically.
Discuss realistic expectations based on your individual anatomy and prescription range.
When selecting a provider for your enhancement evaluation, consider consulting verified refractive surgeons who specialize in complex cases and have experience with enhancement procedures. Accredited eye surgery centers that maintain proper diagnostic equipment can ensure accurate assessment of your candidacy factors.
Understanding your candidacy for enhancement requires specialized evaluation by a qualified refractive surgeon who can assess your unique anatomical factors and visual goals. For international patients coordinating care across borders, planning for follow-up access and potential complications is an essential part of the decision process. International patient coordination services can help facilitate communication between your home care team and your surgical provider.
